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Introduction
The nuclear lamina is part of the nuclear envelope in multicellular 
eukaryotes opposing the inner nuclear membrane (Hutchison 
and Worman, 2004; Gruenbaum et al., 2005). The major com-
ponents of the nuclear lamina are type V intermediate fi  lament 
proteins referred to as lamins (Hutchison, 2002; Shumaker 
et al., 2003) and various lamin-binding proteins (Burke and 
Stewart, 2002). In mammals, at least one of the B-type lamins, 
encoded by LMNB1 and LMNB2, is constitutively expressed 
and essential for cell viability. The A-type lamins A and C, en-
coded by LMNA, are expressed in most terminally differentiated 
somatic cells but are absent in early embryos and some undif-
ferentiated cells. Interestingly, lamins A and C are also found in 
the nucleoplasm as discrete foci, fi  lamentous structures, or are 
uniformly distributed throughout the nucleus (Dechat et al., 
2000) and have been implicated in chromatin organization 
(Gruenbaum et al., 2005), DNA replication (Moir et al., 2000), 
RNA Pol II–dependent transcription (Spann et al., 2002), and 
control of gene expression (Gruenbaum et al., 2005).
Aside from lamins, numerous lamin-binding proteins are 
also considered to be important components of the nuclear lam-
ina and of nucleoplasmic lamin structures (Foisner, 2001; Burke 
and Stewart, 2002). Among the best-studied lamin-binding 
  proteins are the LAP2 family members. Of the six alternatively 
spliced LAP2 isoforms, four—LAP2β, -γ, -δ, and -ε—are 
type II membrane proteins in the inner nuclear membrane (Harris 
et al., 1994; Berger et al., 1996) and bind lamin B (Foisner and 
Gerace, 1993; Furukawa et al., 1998). LAP2α is structurally 
and functionally different. It shares only the NH2 terminus with 
the other isoforms and contains a unique COOH terminus. 
LAP2α is localized throughout the nucleus (Dechat et al., 1998; 
Vlcek et al., 1999) and has been identifi  ed as a specifi  c binding 
partner of nucleoplasmic A-type lamins (Dechat et al., 2000).
All LAP2 isoforms as well as the inner nuclear membrane 
proteins emerin and MAN1 share a common structural motif 
called the LAP2–emerin–MAN1 (LEM) domain (Lin et al., 
2000), which mediates binding to BAF (barrier to autointegra-
tion factor), an essential, highly conserved DNA-binding  protein 
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in eukaryotes (Segura-Totten and Wilson, 2004). Based on these 
interactions, LEM domain proteins in the nuclear lamina and 
the nuclear interior have been implicated in chromatin organiza-
tion (Dechat et al., 2004; Segura-Totten and Wilson, 2004).
Mutations in the LMNA gene have been shown to cause 
a variety of inherited human diseases (laminopathies) that affect 
different tissues, including skeletal muscle, heart, adipose 
  tissue, peripheral nerves, and skin, or cause premature aging 
(Burke and Stewart, 2002; Hutchison and Worman, 2004; 
Mounkes and Stewart, 2004). The molecular basis of these 
  diseases is still unclear. Besides structural defects in lamin com-
plexes, it has also been suggested that disease-causing  mutations 
in LMNA may interfere with the proposed gene regulatory func-
tions of lamins (Hutchison and Worman, 2004). Among several 
reported interactions of lamina proteins with transcriptional 
  activators or repressors (Gruenbaum et al., 2005), the interaction 
of A-type lamins (Ozaki et al., 1994) and of nucleoplasmic 
 lamin  A/C–LAP2α complexes (Markiewicz et al., 2002) with 
the retinoblastoma (Rb) protein may also regulate gene expres-
sion via infl   uencing Rb activity. Rb regulates progression 
through the cell cycle at the G1→S-phase transition by inhibiting 
the activity of E2F-type transcription factors in a phosphory-
lation-dependent manner and by mediating epigenetic changes 
on the promoter region of E2F/Rb target genes (Frolov and Dyson, 
2004). It has been shown that Rb is required for the terminal 
differentiation of many tissues, including adipose and muscle 
tissue (Hansen et al., 2004; Huh et al., 2004), which are also af-
fected in laminopathies. Based on these data, an intriguing lam-
inopathy disease model has recently been raised, arguing that 
lamin A/C complexes may cooperate with Rb in controlling cell 
cycle progression and differentiation of mesenchymal stem 
cells during tissue regeneration and turnover. Disease-causing 
Figure 1.  Overexpression of LAP2𝗂 negatively affects cell cycle progression. (A) Stable HeLa Tet-on clones expressing myc-tagged LAP2α under the control 
of a doxycyclin-dependent promoter were grown in the absence or presence of doxycyclin and processed for immunoﬂ  uorescence microscopy and immuno-
blot analyses of cell lysates. Cells grown permanently in the absence (−Dox) or presence (perm Dox) of doxycyclin or cells transferred to doxycyclin me-
dium upon splitting at day 0 were seeded into plates, and cumulative cell numbers were determined. (B) Stable 3T3 cells expressing a LAP2α-GFP fusion 
or untransfected control cells were analyzed as in A. Cumulative cell numbers were analyzed in cultures grown in complete medium (10% FCS) or upon se-
rum starvation in 0.5% FCS for 7 d before the addition of complete medium (0.5→10%). Graphs show one representative dataset from at least three inde-
pendent experiments. Bars, 10 μm. (C) DNA ﬂ  ow cytometry of dense LAP2α-myc HeLa tet-on cultures grown in the absence or presence of doxycyclin and 
of 3T3 and LAP2α-GFP cells after 7 d of serum starvation (0.5% FCS) and at different time points after restimulation (10% FCS). Numbers at the bottom indi-
cate percentages of cells in G1 and S phase.LAP2α IN CELL CYCLE CONTROL • DORNER ET AL. 85
mutations in LMNA or a lack of lamin A/C may affect the bal-
ance between proliferation and differentiation in stem cells, 
leading to a defect in tissue regeneration (Gotzmann and Foisner, 
2005). Intriguingly, mutations in the gene encoding the nucleo-
plasmic lamin A/C–interacting protein LAP2α has recently 
been linked to dilated cardiomyopathy in humans, clinically 
  resembling lamin A–linked disease phenotypes (Taylor et al., 
2005). As LAP2α is only expressed at very low levels in differ-
entiated muscle, it is hard to imagine how mutations in LAP2α 
can lead to the disease phenotype in fully differentiated heart 
muscle cells. Therefore, it is tempting to speculate that LAP2α, 
which has previously been shown to mediate the nuclear reten-
tion of Rb (Markiewicz et al., 2002), may also be involved in 
Rb-mediated control of cell cycle progression and differentia-
tion in muscle precursor cells. Deregulation of this function in 
patients expressing the disease variant of LAP2α may then lead 
to impaired tissue turnover.
In this study, we investigate whether LAP2α can affect 
cell cycle progression and differentiation. We found that LAP2α 
inhibits progression from G1 to S phase and initiates early 
stages of differentiation in an in vitro adipocyte differentiation 
culture model. We further show that the cell cycle and differen-
tiation regulatory function of LAP2α requires Rb and involves 
regulation of the activity of E2F transcription factors.
Results
LAP2𝗂 expression levels affect 
cell cycle progression
To test the infl  uence of LAP2α expression levels on cell cycle 
progression, we used two different cell models. First, we gener-
ated stable HeLa cell clones expressing a myc-tagged LAP2α 
under the control of a doxycyclin-dependent promoter, which 
allowed analysis of the cell cycle phenotypes in a single cell 
clone expressing different levels of LAP2α. Although HeLa 
cells are transformed by human papilloma virus E7 oncogene 
(Helt and Galloway, 2003), they retain a certain level of cell 
  cycle control, as shown by their growth-inhibitory response to 
serum starvation (see serum starvation data in Fig. 2). LAP2α-
myc HeLa cells grown in the absence of doxycyclin expressed 
exclusively endogenous LAP2α, which is shown by immuno-
fl  uorescence microscopy and immunoblot analyses of total cell 
lysates. The addition of doxycyclin to the culture medium in-
duced the expression of myc-tagged LAP2α in the nucleoplasm 
(Fig. 1 A), giving rise to a total LAP2α level twice as high as 
that in uninduced cells. Cells grown in the absence of doxycy-
clin proliferated signifi  cantly faster than the cells grown perma-
nently in doxycyclin-containing medium (18- vs. 22-h doubling 
times; Fig. 1 A). When doxycyclin was added to cells only upon 
seeding into culture dishes, they showed intermediate growth 
rates ( 20-h doubling time; Fig. 1 A). The addition of doxy-
cyclin to untransfected cells had no infl  uence on cell growth 
  (Vlcek et al., 1999). Interestingly, the cell proliferation-inhibitory 
effect of LAP2α was most prominent in dense cultures. DNA 
fl  ow cytometry analyses in dense cultures grown in the absence 
or presence of doxycyclin (Fig. 1 C) showed a slight increase 
in the relative number of cells in G1 phase (63→70%) and a 
  decrease in S-phase cells (24→19%) upon doxycyclin addition. 
In addition, we showed previously by BrdU incorporation 
  assays that transient overexpression of LAP2α leads to a reduc-
tion in cells in S phase (Vlcek et al., 2002). Therefore, we con-
cluded that increased LAP2α protein levels negatively affect 
G1→S-phase transition.
To confi  rm this result in a cell system with an intact cell 
cycle checkpoint control mechanism, we stably expressed a 
LAP2α-GFP fusion protein in mouse 3T3 fi  broblasts. As shown 
by immunoblot analyses of cell lysates and by immunofl  uores-
cence microscopy, stable 3T3 cell clones expressed roughly 
equal amounts of ectopic LAP2α-GFP and endogenous LAP2α, 
both of which localized to the nucleoplasm (Fig. 1 B). In three 
independent clones of LAP2α-GFP–expressing cells, we found 
a subtle but reproducible reduction in their cell proliferation 
rate compared with that of untransfected or GFP-expressing 
control cells under optimal culture conditions (10% FCS). DNA 
fl  ow cytometry also revealed a slight increase in G1-phase cells 
upon LAP2α-GFP expression (not depicted), indicating an in-
hibitory role of LAP2α on G1→S-phase progression. However, 
because both control cells and LAP2α-GFP–expressing cells 
showed an effi  cient cell cycle arrest in dense cultures (Fig. 1 B), 
the proliferation-inhibitory role of LAP2α may not be detect-
able as clearly as in dense HeLa cells, which have a compro-
mised, although not completely inhibited, density-mediated 
growth control.
Figure 2.  Reduced LAP2𝗂 levels favor cell cycle progression. (A) HeLa 
cells were stably transfected with a LAP2α-speciﬁ  c shRNA vector construct 
(LAP2α RNAi) or with a construct targeting ﬁ  reﬂ   y luciferase (ctrl). Cells 
were analyzed by immunoﬂ  uorescence microscopy using monoclonal anti-
LAP2α antibody and by immunoblot analyses of total cell lysates using 
anti-LAP2 antibody (detecting both LAP2α and LAP2β). Bar, 10 μm. Note 
that the LAP2α RNAi immunoﬂ  uorescence image was overexposed to de-
tect cells. (B) Cumulative cell numbers were determined within 7 d of cul-
ture in complete medium (10% FCS) or in low serum medium (0.5% FCS). 
Graphs show the dataset of one of three independent clones showing the 
same phenotype. (C) DNA ﬂ  ow cytometry of control and LAP2α-deﬁ  cient 
(LAP2α RNAi) cells grown in low serum medium for 4 d.JCB • VOLUME 173 • NUMBER 1 • 2006  86
Therefore, we used an alternative approach and forced 
3T3 cells into cell cycle arrest by serum starvation (0.5% FCS) 
for 7 d before we induced cell cycle entry by the addition of 
complete medium. DNA fl  ow cytometry revealed that LAP2α- 
GFP–expressing cells showed a signifi  cantly delayed reentry 
into S phase (Fig. 1 C) and a persistent growth reduction within 
7 d after induction (Fig. 1 B) when compared with untransfected 
or GFP-expressing cell clones. We concluded that increased 
LAP2α protein levels only weakly affected cell proliferation 
in growing 3T3 cells but interfered with pathways regulating 
G0/G1 phase to S-phase transition.
Having shown that the overexpression of LAP2α nega-
tively affects proliferation and cell cycle entry, we wondered 
whether reduced levels of LAP2α would have opposing effects. 
Although stable RNAi-mediated down-regulation of LAP2α 
was not achieved in 3T3 fi  broblasts, stable HeLa cell clones 
with reduced levels of LAP2α were generated successfully. 
  Immunoblot analyses of total cell lysates showed that unlike an 
unrelated control RNAi construct (targeting fi  refl  y luciferase), 
stable transfection with a LAP2α-specifi  c short hairpin RNA 
(shRNA) construct reduced endogenous LAP2α to <10% of 
the protein level in control cells, whereas the expression of 
LAP2β remained unchanged (Fig. 2 A). In addition, immuno-
fl  uorescence microscopy of LAP2α knockdown versus control 
cells revealed a signifi  cant down-regulation of LAP2α protein. 
As expected, the proliferation rate of LAP2α knockdown cell 
clones was increased signifi  cantly compared with that of con-
trol cells even in optimal growth conditions (Fig. 2 B, 10% FCS). 
Interestingly, in low serum conditions (0.5% FCS), control 
cells exhibited a very low proliferation rate (45-h doubling 
time), whereas proliferation of LAP2α knockdown cells was 
similar to that in complete medium (25-h doubling time). 
DNA fl  ow cytometry confi  rmed that LAP2α-defi  cient cells 
were not as effi  ciently arrested in G1 phase as control cells in 
low serum medium (Fig. 2 C). Altogether, we concluded that 
LAP2α is involved in cell cycle entry/exit checkpoints and/or in 
G1→S-phase transition.
LAP2𝗂 interacts with Rb in the COOH 
terminus and associates with E2F/Rb 
promoter sequences in vivo
Next, we wanted to gain more insights into the molecular basis 
of LAP2α’s effect on the cell cycle. Our previous data revealed 
that LAP2α bound to hypophosphorylated Rb (Markiewicz 
et al., 2002), which is the predominant Rb form in G1 phase of 
proliferating cells or in resting cells in G0 phase. Hypophos-
phorylated Rb blocks transition into S phase by inhibiting the 
activity of E2F transcription factors that are essential for the ex-
pression of S phase–specifi  c genes (Classon and Harlow, 2002). 
Therefore, we reasoned that overexpressed LAP2α may bind 
Rb and, in turn, affect its E2F-repressing activity. To analyze 
the interaction of LAP2α and Rb in more detail, we narrowed 
down the Rb interaction domain in LAP2α. In vitro–translated 
and [
35S]methionine-labeled Rb was overlaid onto transblotted 
  fragments of LAP2α. Full-length protein (aa 1–693) as well as 
NH2-terminally truncated LAP2α fragments missing either the 
Figure 3.  LAP2𝗂 binds to Rb at its COOH ter-
minus and associates with Rb, lamin A/C, and 
E2F promoter sequences in vivo. (A) Schematic 
drawing of LAP2α and LAP2α fragments used 
for binding studies and localization of molecu-
lar domains and interaction regions with Rb 
and lamins A/C in the polypeptide. Numbers 
denote amino acid positions; +, interaction; 
−, no interaction of respective LAP2α frag-
ments with Rb. Light gray boxes denote the 
constant LAP2 regions, including LEM-like and 
LEM domains (hatched). Medium gray denotes 
the α-speciﬁ  c region, whereas dark gray indi-
cates the chromatin interaction domain. On 
the right, in vitro–translated 
35S-labeled Rb 
was overlaid onto transblotted recombinant 
LAP2α fragments. A Ponceau S stain of the 
  respective blot and an autoradiogram of the 
overlay are shown. Numbers on the right indi-
cate molecular masses in kD. (B) HeLa cells 
stably expressing LAP2α-GFP were ﬁ  xed  in 
formaldehyde, mechanically lysed by sonica-
tion, and LAP2α was immunoprecipitated us-
ing monoclonal (m) or polyclonal (p) antibody 
to LAP2α. Control precipitations were per-
formed with antibody-free medium (ctrl) and 
with preimmune serum (PI). Immunoblots of 
  immunoprecipitates and respective inputs (IP, 
diluted 1:10) with antiserum to LAP2α, Rb, or 
monoclonal antibody to lamin A/C are shown. 
(C) Chromatin immunoprecipitation was per-
formed from HeLa and 3T3 cells using mono-
clonal and polyclonal antibody to LAP2α, 
preimmune serum, or anti-acetylhistone H4 (H4), and E2F-dependent promoter sequences in the cyclin D1 and thymidine kinase (TK) genes were ampliﬁ  ed 
by PCR. As a negative control, the presence of histone H4 or E-cadherin promoter sequences was tested. Ethidium bromide–stained DNA fragments in 
  agarose gels are shown. IP, 1% input.LAP2α IN CELL CYCLE CONTROL • DORNER ET AL. 87
LEM-like domain (aa 81–693) or the LAP2 common domain 
(including the LEM-like and LEM domain; aa 188–693) 
strongly interacted with Rb (Fig. 3 A). Because a COOH-terminal 
LAP2α fragment (aa 410–693) and a fragment missing the last 
COOH-terminal 78 residues (aa 1–615) also bound Rb, al-
though less strongly than the other construct, we concluded that 
the Rb interaction domain of LAP2α is located in LAP2α’s 
unique COOH-terminal domain between aa 415–615, but resi-
dues downstream of aa 615 may also contribute to the interac-
tion (Fig. 3 A). Intriguingly, the Rb interaction domain is located 
next to the previously identifi  ed lamin A/C interaction domain 
(Fig. 3 A; Dechat et al., 2000). Thus, it may well be possible 
that LAP2α, lamin A/C, and Rb form a trimeric complex in 
cells, as previously suggested based on coimmunoprecipitation 
of these proteins from lysates of untransformed human dermal 
fi  broblasts (Markiewicz et al., 2002). To test whether this com-
plex can also be formed in transformed HeLa cells, in which at 
least part of Rb is bound to E6 and E7 oncoproteins, we immuno-
precipitated LAP2α complexes from LAP2α-GFP–expressing 
HeLa cells and analyzed samples by immunoblotting. As shown 
in Fig. 3 B, LAP2α/LAP2α-GFP immunoprecipitates obtained 
with a monoclonal antibody (m) or a polyclonal serum to 
LAP2α (p) contained Rb and lamin A/C. Control precipitations 
with mouse IgG (Fig. 3 B, ctrl) or preimmune serum (Fig. 3 B, 
PI) did not pull down any of these proteins. Thus, LAP2α– lamin 
A/C–Rb complexes also exist in transformed HeLa cells and 
could potentially be involved in the aforementioned cell cycle 
regulatory function of LAP2α (Figs. 1 and 2).
We were unable to detect E6, E7, and E2F proteins in cell 
lysates and immunoprecipitates most likely as a result of their 
low concentrations in the samples. Therefore, to test the associa-
tion of LAP2α with E2F complexes, we performed chromatin 
immunoprecipitation with monoclonal and polyclonal LAP2α 
antibodies and tested the association of LAP2α with endogenous 
E2F-dependent promoters (Fig. 3 C). Intriguingly, unlike the pre-
immune serum (Fig. 3 C, PI), both antibodies pulled down DNA 
fragments containing E2F-dependent promoter sequences of the 
thymidine kinase (Fig. 3 C, TK) genes in HeLa and 3T3 cells. 
Furthermore, the E2F-dependent promoter sequence of cyclin 
D1 was effi  ciently precipitated by monoclonal LAP2α   antibody 
(Fig. 3 C, m) in 3T3 and HeLa cells and by LAP2α   antiserum 
(Fig. 3 C, p) in HeLa cells, whereas promoter sequences of the 
E2F-independent genes histone H4 and E-cadherin were not de-
tected in the immunoprecipitates over background level. In con-
trast, antibodies to acetylated histone H4 as a positive control 
pulled down all DNA sequences tested. Thus LAP2α complexes 
specifi  cally bind to E2F-dependent promoter   sequences in vivo.
LAP2𝗂 affects E2F-dependent transcription
To test whether LAP2α may affect E2F-dependent promoter 
activity, we tested the effect of overexpressed LAP2α in an 
E2F-dependent luciferase reporter assay. Proliferating 3T3 cul-
tures exhibited a basal reporter activity, which was induced 
threefold upon the transient expression of E2F-1. Coexpression 
of E2F-1 and Rb reduced reporter activity to basal levels as 
  expected because Rb can sequester and inactivate free active 
E2F-1 (Fig. 4 A). Importantly, the coexpression of LAP2α with 
E2F-1 also decreased the reporter activity as effectively as Rb, 
whereas an NH2-terminal LAP2α fragment (LAP2α-N) that did 
not bind Rb (Fig. 3 A) and did not effect cell cycle progression 
Figure 4.  LAP2𝗂 reduces E2F transcription activity in an Rb-dependent 
manner. Asynchronous 3T3 cells (A), 3T3 cells synchronized by an over-
night aphidicolin block and release from the block for different time pe-
riods (B), aphidicolin-arrested cells (G1 phase) and 4-h released cells 
(S phase; C), or TKO mouse ﬁ  broblasts lacking pocket proteins Rb, p107, 
and p130 (D) were used for E2F-reporter assays. Cells were transfected 
with an E2F-dependent luciferase reporter and a β-galactosidase expres-
sion construct (for normalization of transfection efﬁ  ciencies) together with 
empty vectors (−) or expression vectors encoding E2F-1, Rb, LAP2α, and 
LAP2α N terminus (LAP2α-N). Reporter activity was measured 24 h after 
transfection. Relative activities were calculated by referring measured light 
units to that of the respective controls (reporter plasmids with empty vectors).   
Data represent mean values of at least three independent datasets, and 
SDs (error bars) are shown. DNA ﬂ  ow cytometry proﬁ  les of synchronized 
3T3 cells at different stages of the cell cycle and immunoblot analysis of 
  total cell lysates of untreated (−) or aphidicolin-treated 3T3 cells and of 
transformed HEK cells are shown in B.JCB • VOLUME 173 • NUMBER 1 • 2006  88
in HeLa cells (Vlcek et al., 2002) had no signifi  cant infl  uence 
on E2F-dependent activity. Thus, full-length LAP2α effi  ciently 
inhibited exogenous E2F-dependent activity, which is consistent 
with the negative effect of LAP2α on cell proliferation and cell 
cycle reentry.
So far, we have shown that LAP2α interferes with the 
  activity of overexpressed ectopic E2F-1. To confi  rm this result 
under more physiological conditions, we wanted to analyze the 
effect of LAP2α on the activity of endogenous E2F. As ex-
pected, endogenous E2F-dependent activity was low in aphidi-
colin-treated cells, which were arrested at the G1→S-phase 
transition (shown by DNA fl  ow cytometry; Fig. 4 B). Aphidicolin-
arrested 3T3 cells also contained predominantly hypophos-
phorylated Rb that migrates faster on SDS PAGE, whereas 
proliferating 3T3 cells revealed an Rb double band, refl  ecting 
hyper- and hypophosphorylated forms. Thus, unlike trans-
formed HEK cells (shown as a control in Fig. 4 B), aphidicolin-
treated 3T3 cells were effi  ciently arrested at the G1–S-phase 
boundary. Upon the release of cells from the block, they syn-
chronously proceeded through S phase, and E2F-dependent ac-
tivity was increased 2–6 h after the release, whereas it declined 
again after 8–10 h when cells were in late S/G2 phase (Fig. 4 B). 
We measured the effect of overexpressed LAP2α on endoge-
nous activity at two different cell cycle stages: in late G1 phase 
(aphidicolin arrested), when E2F-dependent activity is low 
  because of the expression of hypophosphorylated Rb, and in 
S phase (4 h after release), when E2F-dependent activity is high. 
In G1 phase, a low basal E2F-dependent activity was further 
  reduced (twofold) upon the expression of exogenous Rb or of 
LAP2α (Fig. 4 C). In contrast, in S-phase cells with a higher 
basal E2F-dependent activity, LAP2α expression was unable to 
repress E2F-dependent activity, whereas overexpressed Rb still 
reduced it up to twofold (Fig. 4 C). These results imply that 
LAP2α can repress E2F-dependent activity through hypophos-
phorylated Rb in G1 phase, which is consistent with our previ-
ous data that LAP2α binds preferentially to the G1 phase–specifi  c 
hypophosphorylated Rb (Markiewicz et al., 2002). Overall, our 
studies strongly support a role of LAP2α in regulating E2F-
  dependent activity in an Rb-dependent manner.
Having shown that LAP2α binds to promoter sequences 
of endogenous E2F target genes, we wondered whether over-
expressed LAP2α also affects the expression of these genes. 
As E2F target genes are differentially expressed during the cell 
cycle, we arrested 3T3 control cells and LAP2α-GFP– expressing 
3T3 cells in G0 phase by serum starvation. After reentry into the 
cell cycle by serum addition, we analyzed mRNA levels of three 
known E2F target genes (cyclin D1, thymidine kinase, and 
  cyclin E) and of one E2F-independent control gene (actin) by 
semiquantitative RT-PCR. As expected, unlike actin mRNA, the 
mRNA levels of all three E2F target genes in control 3T3 cells 
increased between 10 and 14 h after serum addition (Fig. 5), 
when cells   proceeded to the G1–S-phase boundary (for DNA 
fl  ow   cytometry, see Fig. 1 C). In LAP2α-GFP–expressing 3T3 
cells, the increase in E2F target gene mRNAs was delayed by 
 5 h compared with the control (Fig. 5). These fi  ndings are 
  consistent with an inhibitory function of LAP2α repressing en-
dogenous E2F target gene expression.
LAP2𝗂 function in cell cycle progression 
depends on Rb
Our fi  ndings could be explained if LAP2α regulates cell cycle 
progression by binding to hypophosphorylated Rb and, as a 
consequence, increases Rb’s repressor function or delays its 
deactivation during G1→S-phase transition. However, we can-
not fully exclude the possibility that LAP2α inhibits E2F ac-
tivity via an Rb-independent function. To address this question 
directly, we performed E2F reporter assays in triple knockout 
(TKO) mouse embryonic fi  broblasts (MEFs) in which all three 
pocket proteins (Rb, p107, and p130) were knocked out (Sage 
et al., 2000). These cells express normal levels of LAP2α and 
lamins A/C compared with wild-type fi  broblasts (unpublished 
data). Endogenous E2F activity was not affected by the over-
expression of LAP2α in TKO MEFs (Fig. 4 D). In contrast, the 
expression of Rb alone or in combination with LAP2α reduced 
E2F activity to a similar level (approximately twofold), al-
though the coexpression of Rb and LAP2α was slightly more 
effective than Rb alone. The high level of Rb expression in 
these transient transfection assays is most likely suffi  cient to 
effectively repress E2F activity so that the additional expres-
sion of LAP2α may not signifi  cantly increase this activity. 
Overall, we concluded that LAP2α’s effect on E2F activity is 
strictly dependent on the presence of the pocket proteins Rb, 
p107, or p130.
Figure 5.  Overexpressed LAP2𝗂 affects the expression of endogenous 
E2F target genes. mRNA levels of the E2F target genes cyclin D1, thymi-
dine kinase, and cyclin E and of actin as a control were determined by 
semiquantitative RT-PCR from control 3T3 cells (solid lines) or LAP2α-GFP–
expressing 3T3 cells (dotted lines) harvested 0–24 h after serum addition 
to serum-starved cultures. Ethidium bromide–stained DNA fragments in 
agarose gels (bottom) were quantiﬁ  ed by QuantiScan and plotted against 
incubation times (top).LAP2α IN CELL CYCLE CONTROL • DORNER ET AL. 89
LAP2𝗂 overexpression initiates 
the adipocyte differentiation program
The Rb–E2F pathway is essential for the differentiation of sev-
eral cell types, including skeletal muscle (Huh et al., 2004) and 
adipocytes (Hansen et al., 2004). To test whether LAP2α-mediated 
regulation of the Rb–E2F pathway can also infl  uence differenti-
ation, we used the 3T3 F442A clone. These cells proliferate in 
normal culture medium and can be considered as preadipocytes, 
whereas the addition of insulin and triiodothyronine (T3) to the 
culture medium induces cell cycle arrest and differentiation into 
mature adipocyctes within 10 d, as seen in the phase-contrast 
microscope by a morphological change from spindlelike pread-
ipocytes to rounded adipocytes with numerous fat droplets (Fig. 
6 A). Immunoblot analyses of total cell lysates revealed a switch 
from the high molecular weight hyperphosphorylated Rb in 
proliferating cells to the low molecular weight hypophosphory-
lated form in adipocytes, refl  ecting cell cycle arrest in G0 phase 
(Fig. 6 B). Furthermore, LAP2α appeared as a double band in 
proliferating cells, representing mitotic hyperphosphorylated 
and interphase hypophosphorylated LAP2α (Dechat et al., 
1998), whereas the hypophosphorylated form accumulated in 
differentiated adipocytes because of the lack of mitotic cells. 
Finally, the adipocyte-specifi  c differentiation marker peroxi-
some proliferator–activated receptor γ (PPARγ; Fajas et al., 
2002b) was expressed exclusively in differentiated cells, and 
lamins A/C were slightly up-regulated in differentiated cells 
(Fig. 6 B). Overall, these data showed that in differentiation 
  medium, preadipocytes enter G0 phase and differentiate to 
  adipocytes in vitro.
To test the effect of overexpressed LAP2α on differentia-
tion, we used clones of the 3T3 F442A cells stably expressing 
LAP2α-GFP, which showed a delayed response in cell cycle 
entry upon serum starvation and restimulation (Fig. 1 B). Cell 
cycle arrest and morphological changes during differentiation 
as detected by phase-contrast microscopy did not differ signifi  -
cantly in several independent clones of LAP2α-GFP– expressing 
versus control cells (untransfected or GFP expressing).   However, 
we did detect signifi  cant differences by immunoblot analyses of 
total cell lysates. Hypophosphorylated Rb, LAP2α, and PPARγ, 
all of which are early markers of adipogenesis, clearly accumu-
lated in proliferating LAP2α-GFP preadipocytes compared 
with control cells, suggesting that the overexpression of LAP2α 
initiated early events in the differentiation pathway, accompa-
nying a partial cell cycle arrest.
Upon insulin/T3 stimulation of LAP2α-GFP cells, hypo-
phosphorylated Rb and LAP2α accumulated similarly to the 
control cells. In contrast, the expression level of PPARγ did 
not reach the levels observed in the control (Fig. 6 B), indicat-
ing that differentiation was incomplete. To test this possibility, 
we stained for differentiation-specifi  c lipid droplets using oil red. 
As shown in Fig. 6 C, LAP2α-GFP–expressing cells had signif-
icantly fewer oil red–positive droplets than control cells. Thus, 
although the overexpression of LAP2α-GFP initiated differen-
tiation events in the absence of insulin and T3, further differen-
tiation did not occur even in the presence of insulin/T3.
Overall, our studies show that LAP2α–lamin A/C 
  complexes regulate G1→S-phase transition via the Rb–E2F 
pathway and control the balance between cell proliferation 
and differentiation.
Discussion
In this study, we analyzed the effects of LAP2α on cell cycle 
progression and differentiation and showed that decreased 
LAP2α levels negatively affected the growth arrest response to 
serum starvation, whereas increased levels delayed the  transition 
from G0 to S phase. We further showed that this function of 
LAP2α is mediated by pocket proteins.
What are the molecular mechanisms of the Rb-mediated 
cell cycle control by LAP2α complexes? Rb regulates the 
Figure 6.  LAP2𝗂 affects adipocyte differentiation. 3T3 F442A cells 
  (control) or 3T3 F442A cells expressing LAP2α-GFP were grown in prolifera-
tion medium (P) or in differentiation medium containing insulin and T3 (D) for 
10 d and were analyzed by phase-contrast microscopy (A), immunoblot 
analyses of total cell lysates (B), and oil red staining (C). White lines indi-
cate that intervening lanes have been spliced out. Bars, 40 μm.JCB • VOLUME 173 • NUMBER 1 • 2006  90
  activity of E2F transcription factors, which control the expres-
sion of cell cycle regulatory genes (Classon and Harlow, 2002; 
Frolov and Dyson, 2004). In noncycling cells, Rb is hypophos-
phorylated and is active as a transcriptional repressor. Hypo-
phosphorylated Rb is bound to E2F transcription factors, blocks 
its transactivation domain, inhibits the recruitment of preinitia-
tion complexes, and represses genes directly by recruiting 
chromatin -modifying proteins, including histone deacetylase 
HDAC1 (Brehm et al., 1998), methyl transferase Suv39h, and 
heterochromatin protein HP1 (Nielsen et al., 2001; Ait-Si-Ali 
et al., 2004). Through sequential phosphorylation of Rb by cyclin
D and E–dependent kinases (Mittnacht, 1998), Rb is released 
from E2F, causing its activation as a transcription factor. Based 
on our previous fi  ndings (Dechat et al., 2000; Markiewicz et al., 
2002; Vlcek et al., 2002) and results reported here, we postulate 
that nucleoplasmic LAP2α–lamin A/C complexes bind hypo-
phosphorylated Rb, thereby delaying its deactivation and main-
taining E2F in a repressed state.
The molecular mechanisms as to how LAP2α–lamin 
A/C complexes exert their regulatory function on Rb are un-
known. However, several possibilities can be envisaged: fi  rst, 
LAP2α may regulate Rb phosphorylation. LAP2α preferen-
tially bound to Rb phosphorylated on serine 780, which is the 
fi  rst serine to be targeted at the G1→S-phase transition (Lundberg 
and Weinberg, 1998). Recruitment of Rb-S780 to LAP2α–
  lamin A/C may delay the phosphorylation of downstream 
sites. Alternatively, LAP2α–lamin A/C complexes may favor 
the dephosphorylation of Rb, leading to its deactivation. 
In line with the latter hypothesis, Van Berlo et al. (2005) have 
recently shown that in Lmna knockout fi  broblasts, TGFβ-
  mediated cell cycle arrest is impaired through a less effi  cient 
phosphatase PP2A-mediated dephosphorylation of Rb. Second, 
LAP2α–lamin A/C may recruit regulatory proteins to the 
Rb complex. Third, LAP2α–lamin A/C may recruit Rb–
E2F complexes to subnuclear compartments or chromatin 
  regions. Our fi  ndings that LAP2α complexes associate with 
E2F-  dependent promoter regions imply that the cell cycle 
regulatory activity of LAP2α acts directly on the promoter of 
E2F target genes. Fourth, in view of the reported destabiliza-
tion of Rb in Lmna
−/− fi  broblasts by proteasomal degradation 
(Johnson et al., 2004), the interaction of Rb with LAP2α–
  lamin A/C complexes may stabilize the proteins. However, 
this would imply that proteasomal degradation also contrib-
utes to the  deactivation of Rb repressor activity at the G1→  S-phase 
transition, although no direct evidence for this has been 
  reported so far. Furthermore, we did not see any changes in 
Rb protein level upon the overexpression or knockdown of 
LAP2α.   Finally, it should be mentioned that another LAP2 
isoform, LAPß, was also found to down-regulate E2F activity, 
although the mechanisms are most likely different from that 
of LAP2α, involving the binding of LAP2β to the protein 
germ cell less (Nili et al., 2001) and to histone deacetylase 3 
(Somech et al., 2005).
What is the physiological relevance of LAP2α–lamin A/C 
complexes in cell cycle control? In cycling cells, these proteins 
may provide additional checkpoint mechanisms, preventing 
premature entry into S phase. However, we consider it more 
likely that LAP2α–lamin A/C complexes are involved in con-
trolling cell cycle exit during the differentiation of adult stem 
cells. Rb has been found to be essential for the differentiation of 
various tissues, including skeletal muscle and adipocytes (Hansen 
et al., 2004; Huh et al., 2004). Inactivation of the Rb gene in 
proliferating myoblasts and in differentiated muscle fi  bers in 
mice revealed that Rb is required for the initiation of myogenic 
differentiation but not for the maintenance of the terminal dif-
ferentiation state (Huh et al., 2004). Also in adipocyte differen-
tiation, Rb facilitates the initiation of differentiation by inducing 
cell cycle arrest (Fajas et al., 2002a). Thus, Rb seems to be in-
volved in maintaining a balance between proliferation and dif-
ferentiation in adult stem cells (Classon et al., 2000). Adult stem 
cells do not proliferate but enter the cell cycle upon specifi  c sig-
nals and self propagate to maintain a stable population of stem 
cells in the tissue. At the same time, they differentiate to regen-
erate damaged tissue or maintain a basic turnover of differenti-
ated cells (Wagers and Weissman, 2004). Our data suggest that 
LAP2α–lamin A/C complexes are essential cofactors of Rb in 
maintaining the balance between proliferation and differentia-
tion in adult stem cells. Similar to Rb, LAP2α’s critical role 
would be in transit amplifi  er cells rather than in terminally dif-
ferentiated cells. Consistent with this hypothesis, the highest 
levels of LAP2α expression during the differentiation of skele-
tal muscle satellite cells is just before entry into a postmitotic 
state (Markiewicz et al., 2005). Moreover, by artifi  cially main-
taining high levels of LAP2α expression in preadipocytes, early 
events in differentiation were enhanced but terminal differentia-
tion was inhibited (Fig. 6). Therefore, we propose that the 
LAP2α–lamin A/C complex is critical for Rb-mediated entry of 
adult stem cells into a postmitotic state but is not required for 
terminal differentiation.
During the last 10 yr, geneticists have identifi  ed mutations 
in the human LMNA gene that give rise to pathological pheno-
types in muscle, adipose, bone, neuronal, and skin tissue or 
cause premature ageing (Burke and Stewart, 2002; Mounkes 
and Stewart, 2004). Mice lacking lamin A/C or expressing mu-
tated lamin A/C show similar phenotypes (Sullivan et al., 1999; 
Mounkes et al., 2003; Arimura et al., 2005). The molecular ba-
sis of these diseases is unclear. It may involve structural defects 
in mutated lamins, leading to nuclear fragility, or deregulated 
functions of lamins in gene expression (Hutchison and Worman, 
2004). As LAP2α is involved in targeting a subfraction of lamin 
A/C to the nucleoplasm (Dechat et al., 2000, 2004), it may 
be relevant for the nucleoplasmic functions of lamin A/C. If 
  nucleoplasmic lamins together with LAP2α control Rb in cell 
cycle progression and differentiation, disease-causing muta-
tions in lamin A/C may cause differentiation defects. In support 
of this model, the expression of a disease-linked lamin A mutant 
in C2C12 myoblasts (Favreau et al., 2004) inhibited the in vitro 
differentiation into myotubes, and the expression of wild-type 
and mutated lamin A inhibited the differentiation of 3T3 
cells into adipocytes (Boguslavsky et al., 2006). We propose 
that disease-causing mutations in A-type lamins perturb the bal-
ance between proliferation and differentiation in adult stem 
cells, leading to less effi  cient tissue regeneration. This model 
would help to explain the late onset of the disease during LAP2α IN CELL CYCLE CONTROL • DORNER ET AL. 91
  childhood or adulthood, an age when tissue regeneration be-
comes relevant, as well as progressive muscle weakness, which 
may be caused indirectly by a defect in regeneration rather than 
by   direct degeneration (Gotzmann and Foisner, 2005). Intrigu-
ingly, mutations in the gene encoding LAP2α have recently 
been linked to laminopathy-like cardiomyopathy (Taylor et al., 
2005). Disease-causing LAP2α mutants bind less effi  ciently to 
lamin A/C, supporting the hypothesis that nucleoplasmic 
LAP2α–  lamin A/C complexes fulfi  ll important functions.
Materials and methods
Cell culture
3T3-F442A and HeLa cells were cultured at 37°C and 8% CO2 in high 
  glucose DME medium supplemented with 10% FCS, 50 U/ml penicillin, 
50 μg/ml streptomycin, 0.2 mM glutamine (Invitrogen), 0.8 μg/ml biotin, 
and 0.4 μg/ml pantothenic acid (Sigma-Aldrich) for 3T3-F442A cells. 
Conﬂ   uent 3T3-F442A cells were differentiated with 17 nM insulin and 
2 nM T3 (Sigma-Aldrich) for 7–10 d. Lipid drops were stained for 1 h with 
0.3% Oil Red O (Sigma-Aldrich) after ﬁ   xation in 3.7% formaldehyde 
(Merck) in PBS for 2 min. For DNA ﬂ  ow cytometry, 5 × 10
5 cells in 1 ml 
PBS were mixed with 4 ml 85% ethanol at −20°C. Cell pellets were brieﬂ  y 
treated with 0.05% aqueous pepsin, stained with 2 μg/ml DAPI and 
15 μg/ml sulforhodamine (Sigma-Aldrich) in 100 mM Tris-HCl, pH 8.0, 2 mM 
MgCl2, and 0.1% Triton X-100, and analyzed with a ﬂ  ow cytometer (PAS II; 
Partec). For cell proliferation assays, 5 × 10
4 cells were seeded onto 
100-mm dishes (Nunc), and cell numbers were determined within 7 d 
  using a coulter counter Z2 system (Scharfe System). For serum starvation, 
cells were grown in medium with 0.5% FCS for 5 d.
Transfections and reporter assays
LAP2α-myc HeLa Tet-on cells (Vlcek et al., 1999) were grown in medium 
with 200 μg/ml hygromycin and induced with 2 μg/ml doxycyclin 
  (Invitrogen). pTD35 encoding LAP2α-GFP was generated by cloning 
LAP2α cDNA via NheI–XhoI from pTD15 into a modiﬁ  ed  pEGFP-N3 
  vector (CLONTECH Laboratories, Inc.) as described previously (Vlcek 
et al., 2002) and was used for stable transfection of 3T3 cells with 
  LipofectAMINE 2000 (Invitrogen). Stable clones were selected in medium 
with 700 μg/ml geneticin.
For reporter assays, cells were cotransfected with 2 μg luciferase 
  reporter p3xE2F-Luc (provided by H. Rotheneder, Medical University of 
  Vienna, Vienna, Austria; Krek et al., 1993) and 2 μg β-galactosidase 
control reporter plasmid pAD-CMV1-βgal (Eger et al., 2000) together 
with various combinations of the following plasmids (1 μg each): pCI-neo-
HA-E2F1 (Rotheneder et al., 1999), pCMV-Rb (provided by M. Busslinger, 
Research Institute of Molecular Pathology, Vienna, Austria; Hinds et al., 
1992), pSV61 (full-length LAP2α in pcDNA3.1), pSV62 (LAP2 common 
in pcDNA3.1), and pcDNA3.1 (Invitrogen). Luciferase activity was mea-
sured with the lumat system (Berthold) and normalized for β-galactosidase 
activity. Relative luciferase activities were calculated as the light units rela-
tive to the reporter plasmid controls. Data were obtained from at least 
three independent experiments, and mean values and standard errors 
were calculated.
RNAi
pSHAG-1 vector containing a human U6 promoter fragment (−265 to 1) was 
derived from pTOPO-ENTR/D (Invitrogen) as described previously (Paddison 
et al., 2002; http://katahdin.cshl.org:9331/RNAi_web/scripts/main2.pl). 
Human LAP2α-speciﬁ   c oligonucleotides encoding a shRNA were de-
signed as described (http:/ /katahdin.cshl.org:9331/homepage/ portal/
scripts/main2.pl?link=protocols&content=protocols.html): 5′-A  C  T  G  A  T-
  C  A  A  T  T  C  T  C  T  T  C  T  G  G  A  A  G  C  T  T  G  C  A  G  A  A  G  A  G  A  A  T  T  G  A  T  C  A  G  T  C  T  T  T  T  T  T  -3′ 
and 5′-G  A  T  C  A  A  A  A  A  A  G  A  C  T  G  A  T  C  A  A  T  T  C  T  C  T  T  C  T  G  C  A  A  G  C  T  T  C  C  A  G  A- 
A  G  A  G  A  A  T  T  G  A  T  C  A  G  T  C  G  -3′. Annealed oligonucleotides were cloned 
into pSHAG-1 via BseRI–BamHI. As a control, we used pSHAG-
FF1 encoding a shRNA targeting ﬁ   reﬂ   y luciferase (gift of Greg
Hannon, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; 
Paddison et al., 2002). Using the Gateway system (Invitrogen), shRNA 
expression cassettes in pSHAG-1 were shuttled into pTRACER-EF/Bsd 
plasmids in which a Gateway-compatible conversion cassette had been 
introduced in a reverse orientation via EcoRV. The resulting RNAi vectors 
(pJG118 targeting LAP2α and pJG121 control vector targeting luciferase) 
were transfected into HeLa cells, and stable clones were selected with 
20 μg/ml blasticidin (Invitrogen).
Chromatin immunoprecipitation and RT-PCR
Chromatin immunoprecipitation was performed as described previously 
(Hauser et al., 2002) with a few modiﬁ  cations. Cross-linking with formal-
dehyde was performed for 15 min, and the soluble chromatin fraction was 
diluted 1:10 in 16.7 mM Tris-HCl, pH 8.0, 167 mM NaCl, 1.2 mM EDTA, 
1.1% Triton X-100, and 0.01% SDS and was precipitated with monoclonal 
antibody 15 or antiserum 245 to LAP2α or rabbit preimmune serum as a 
control. Chromatin–antibody complexes were isolated with 30 μl of pro-
tein A/G–Sepharose beads and solubilized in 2% SDS, 0.1 M NaHCO3, 
10 mM DTT, and 250 mM NaCl overnight at 65°C. Samples were ana-
lyzed by immunoblotting, or DNA was extracted with phenol-chloroform, 
precipitated with ethanol, and dissolved in water. The immunoprecipitated 
DNA was analyzed for cyclin D1, thymidine kinase, E-cadherin, and his-
tone H4 promoter sequences by PCR using a thermocycler (PTC-200; MJ 
Research) and PuReTaq Ready-To-Go PCR beads (GE Healthcare). The lin-
ear range for each primer pair was determined empirically using different 
amounts of genomic DNA. PCR products were resolved on 2% agarose 
gels. Primers used are as follows: 5′-G  A  C  C  C  T  G  G  C  C  A  G  G  A  T  A  A  A  C  -3′ 
and 5′-A  G  A  C  G  A  G  C  C  C  T  A  A  G  C  T  C  T  C  -3′ for mouse cyclin D1; 5′-G  A  C  C-
G  A  C  T  G  G  T  C  A  A  G  G  T  A  G  G  -3′ and 5′-G  T  T  T  C  A  T  T  C  C  G  G  C  G  C  A  C  A  G  G  -3′ for 
human cyclin D1; 5′-A  G  A  C  C  C  C  G  C  A  C  C  T  G  A  A  T  C  T  G  -3′ and 5′-T  T  C  A  C  G  T-
A  G  C  T  G  A  G  A  G  G  T  G  G  -3′ for mouse and 5′-C  G  A  T  C  A  G  C  C  A  C  G  T  C  C  A  T  C  -3′ 
and 5′-C  G  C  C  G  A  C  C  G  C  T  T  T  A  A  A  C  C  -3′ for human thymidine kinase; 5′-G  A-
C  A  C  C  G  C  A  T  G  A  A  A  A  G  A  A  T  A  G  C  T  G  -3′ and 5′-C  T  T  T  C  C  C  A  A  G  G  C  C  T  T  T  A  C  C-
A  C  C   3′ for mouse histone H4; and 5′-A  A  C  T  C  C  A  G  G  C  T  A  G  A  G  G  G  T  C  A  -3′ 
and 5′-G  G  G  C  T  G  G  A  G  T  C  T  G  A  A  C  T  G  A  -3′ for human E-cadherin.
For RT-PCR, poly(A)
+ mRNA was extracted from cells with an mRNA 
Isolation Kit and reverse transcribed using the First Strand cDNA Synthesis 
Kit (both from Roche). Aliquots of the resulting products were used as tem-
plates for speciﬁ  c  PCR  ampliﬁ   cations using PuReTaq Ready-To-Go PCR 
beads (GE Healthcare). The conditions for PCR reactions were optimized 
for each primer pair. All cDNAs were normalized according to actin ex-
pression levels. Primers used are as follows: 5′-A  G  T  G  C  G  T  G  C  A  G  A  A  G  G  A-
G  A  T  T  -3′ and 5′-C  A  C  A  A  C  T  T  C  T  C  G  G  C  A  G  T  C  A  A  -3′ for cyclin D1; 
5′-A  T  G  A  G  C  T  A  C  A  T  C  A  A  T  C  T  G  C  C  C  -3′ and 5′-T  T  C  C  G  A  T  C  A  T  G  T  G  T  G  G  A  G-
A  A  -3′ for thymidine kinase; 5′-C  A  A  A  G  C  C  C  A  A  G  C  A  A  A  G  A  A  A  G  -3′ and 
5′-C  C  A  C  T  G  T  C  T  T  T  G  G  A  G  G  C  A  A  T  -3′ for cyclin E; and 5′-A  T  C  T  G  G  C  A  C  C  A-
C  A  C  C  T  T  C  T  A  C  -3′ and 5′-C  A  G  C  C  A  G  G  T  C  C  A  G  A  C  G  C  A  G  G  -3′ for actin. 
PCR reactions were quantiﬁ  ed with QuantiScan software (Biosoft).
Immunoﬂ  uorescence microscopy
Immunoﬂ  uorescence microscopy and immunoblotting were performed as 
described previously (Vlcek et al., 2002; Dechat et al., 2004). For micros-
copy, samples were mounted in mowiol and analyzed using a microscope 
(Axiovert 200M; Carl Zeiss MicroImaging, Inc.) equipped with a confocal 
laser-scanning unit (LSM510 META; Carl Zeiss MicroImaging, Inc.) and 
α–plan-Fluar 100× NA 1.45 oil (a = 0.11 mm) and plan-Apochromat 
63× NA 1.40 oil differential interference contrast MC27 (a = 0.19 mm) 
objectives (Carl Zeiss MicroImaging, Inc.). Phase-contrast images were taken 
on a microscope (Axiovert 40C; Carl Zeiss MicroImaging, Inc.) equipped 
with a digital camera (PowerShot G5; Canon) and plan-Neoﬂ  uar 10× NA 
0.30 (a = 5.6 mm) and Achromat 20× NA 0.4 objectives. Images were 
prepared with Adobe Photoshop software.
Immunoblotting and blot overlay assays
Total protein lysates of cells for immunoblotting were prepared by dissolv-
ing cells of one 10-cm dish in 500 μl of 2× SDS-PAGE sample buffer. For 
detection of blotted proteins, the Super Signal ECL system (Pierce Chemical 
Co.) was used. The preparation of recombinant LAP2α and blot overlay 
assays was described previously (Dechat et al., 2000).
Antibodies
Primary antibodies used were hybridoma supernatants of antibodies to 
LAP2 and LAP2α (Dechat et al., 1998), rabbit antiserum to LAP2α (Immu-
Quest; Vlcek et al., 2002), monoclonal myc 1-9E10.2 antibody (American 
Type Culture Collection), monoclonal antilamins A/C antibody 1E4 
(a gift of F. McKeon, Harvard Medical School, Boston, MA; Loewinger and 
McKeon, 1988), monoclonal anti-Rb G3-245 (BD Biosciences), monoclo-
nal anti-PPARγ (Santa Cruz Biotechnology, Inc.), polyclonal anti-actin 
(Sigma-Aldrich), and anti-acetylhistone H4 (Upstate Biotechnology). 
  Secondary antibodies were goat anti–mouse IgG and goat anti–rabbit IgG 
conjugated to Texas red (Jackson ImmunoResearch Laboratories), goat JCB • VOLUME 173 • NUMBER 1 • 2006  92
anti–rabbit IgG conjugated to AlexaFluor488 (Invitrogen), and goat anti–
mouse IgG and goat anti–rabbit IgG conjugated to peroxidase (Jackson 
ImmunoResearch Laboratories).
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